{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:30:22Z","timestamp":1790231422985,"version":"4.1.0"},"reference-count":155,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Female Pelvic Med Reconstr Surg"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/spv.0000000000000550","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T09:47:46Z","timestamp":1516873666000},"page":"321-335","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":82,"title":["American Urogynecologic Society Best-Practice Statement: Recurrent Urinary Tract Infection in Adult Women: [WITHDRAWN]"],"prefix":"10.1097","volume":"24","author":[{"given":"Linda","family":"Brubaker","sequence":"first","affiliation":[{"name":"Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Reproductive Medicine, University of California San Diego, San Diego, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Carberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel","family":"Nardos","sequence":"additional","affiliation":[{"name":"Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Oregon Health & Sciences University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charelle","family":"Carter-Brooks","sequence":"additional","affiliation":[{"name":"Division of Urogynecology and Reconstructive Surgery, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry L.","family":"Lowder","sequence":"additional","affiliation":[{"name":"Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Washington University in St Louis, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"7","key":"bib1-20231106","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00192-009-0856-3","article-title":"Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction","volume":"20","year":"2009","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"8","key":"bib2-20231106","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2014.303","article-title":"Urinary tract infections in older women: a clinical review","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"bib3-20231106","doi-asserted-by":"crossref","first-page":"f3140","DOI":"10.1136\/bmj.f3140","article-title":"Diagnosis and management of recurrent urinary tract infections in non-pregnant women","volume":"346","year":"2013","journal-title":"BMJ"},{"issue":"5","key":"bib4-20231106","first-page":"316","article-title":"Guidelines for the diagnosis and management of recurrent urinary tract infection in women","volume":"5","year":"2011","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"bib5-20231106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","year":"2014","journal-title":"Infect Dis Clin North Am"},{"issue":"11","key":"bib6-20231106","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"bib7-20231106","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"3","key":"bib8-20231106","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s15010-007-6180-2","article-title":"Community-onset urinary tract infections: a population-based assessment","volume":"35","year":"2007","journal-title":"Infection"},{"issue":"12","key":"bib9-20231106","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/oxfordjournals.aje.a010170","article-title":"Risk factors for second urinary tract infection among college women","volume":"151","year":"2000","journal-title":"Am J Epidemiol"},{"key":"bib10-20231106","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.urology.2015.11.051","article-title":"Incidence and management of uncomplicated recurrent urinary tract infections in a national sample of women in the United States","volume":"90","year":"2016","journal-title":"Urology"},{"issue":"3","key":"bib11-20231106","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/JCM.02876-13","article-title":"Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder","volume":"52","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"2","key":"bib12-20231106","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s15010-012-0347-1","article-title":"Risk factors for non\u2013Escherichia coli community-acquired bacteriuria","volume":"41","year":"2013","journal-title":"Infection"},{"issue":"16","key":"bib13-20231106","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1073\/pnas.97.16.8829","article-title":"Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses","volume":"97","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"bib14-20231106","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11934-013-0354-5","article-title":"From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections","volume":"14","year":"2013","journal-title":"Curr Urol Rep"},{"issue":"6","key":"bib15-20231106","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4161\/viru.2.6.18189","article-title":"Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation","volume":"2","year":"2011","journal-title":"Virulence"},{"issue":"5629","key":"bib16-20231106","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1084550","article-title":"Intracellular bacterial biofilm-like pods in urinary tract infections","volume":"301","year":"2003","journal-title":"Science"},{"issue":"38","key":"bib17-20231106","doi-asserted-by":"crossref","first-page":"14170","DOI":"10.1073\/pnas.0602136103","article-title":"Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract","volume":"103","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"bib18-20231106","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1086\/515635","article-title":"Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections","volume":"178","year":"1998","journal-title":"J Infect Dis"},{"issue":"1","key":"bib19-20231106","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/313596","article-title":"Recurrent urinary tract infections in postmenopausal women","volume":"30","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"4","key":"bib20-20231106","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0924-8579(00)00350-2","article-title":"Recurrent urinary tract infection in women","volume":"17","year":"2001","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"bib21-20231106","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/315827","article-title":"Risk factors for recurrent urinary tract infection in young women","volume":"182","year":"2000","journal-title":"J Infect Dis"},{"key":"bib22-20231106","first-page":"9","article-title":"Frequency of recurrent urinary tract infection in patients with pelvic organ prolapse","volume":"7","year":"2015","journal-title":"Res Rep Urol"},{"issue":"5 Pt 1","key":"bib23-20231106","first-page":"929","article-title":"Complications and untoward effects of the tension-free vaginal tape procedure","volume":"101","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"10","key":"bib24-20231106","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00192-011-1429-9","article-title":"Risk factors for urinary tract infection following incontinence surgery","volume":"22","year":"2011","journal-title":"Int Urogynecol J"},{"issue":"11","key":"bib25-20231106","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.7205\/MILMED-D-14-00122","article-title":"The incidence of early and recurrent urinary tract infections after midurethral sling operations","volume":"179","year":"2014","journal-title":"Mil Med"},{"issue":"4","key":"bib26-20231106","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.juro.2016.05.036","article-title":"Ten-year followup after tension-free vaginal tape-obturator procedure for stress urinary incontinence","volume":"196","year":"2016","journal-title":"J Urol"},{"issue":"20","key":"bib27-20231106","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/jama.287.20.2701","article-title":"Does this woman have an acute uncomplicated urinary tract infection?","volume":"287","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"bib28-20231106","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1532-5415.2009.02227.x","article-title":"Clinical features to identify urinary tract infection in nursing home residents: a cohort study","volume":"57","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"bib29-20231106","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/fampra\/20.2.103","article-title":"What is the predictive value of urinary symptoms for diagnosing urinary tract infection in women?","volume":"20","year":"2003","journal-title":"Fam Pract"},{"issue":"2","key":"bib31-20231106","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eururo.2007.03.014","article-title":"Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses","volume":"52","year":"2007","journal-title":"Eur Urol"},{"issue":"11","key":"bib32-20231106","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S1701-2163(16)34717-X","article-title":"Recurrent urinary tract infection","volume":"32","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"issue":"11","key":"bib34-20231106","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/cid\/civ696","article-title":"Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"bib35-20231106","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0924-8579(01)00303-X","article-title":"Urinary tract infection in adults: research priorities and strategies","volume":"17","year":"2001","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"bib36-20231106","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0094-0143(05)70401-8","article-title":"Imaging and radiologic management of upper urinary tract infections","volume":"24","year":"1997","journal-title":"Urol Clin North Am"},{"issue":"3","key":"bib37-20231106","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/nau.22998","article-title":"Diagnostic yield of cystoscopy in the evaluation of recurrent urinary tract infection in women","volume":"36","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"bib38-20231106","doi-asserted-by":"crossref","first-page":"46551","DOI":"10.1038\/srep46551","article-title":"Urinary and fecal metabonomics study of the protective effect of Chaihu-Shu-Gan-San on antibiotic-induced gut microbiota dysbiosis in rats","volume":"7","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"bib39-20231106","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"482","key":"bib40-20231106","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","year":"2002","journal-title":"Br J Gen Pract"},{"key":"bib41-20231106","first-page":"h6544","article-title":"Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial","volume":"351","year":"2015","journal-title":"BMJ"},{"key":"bib42-20231106","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1741-7015-8-30","article-title":"Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? Results of a randomized controlled pilot trial","volume":"8","year":"2010","journal-title":"BMC Med"},{"key":"bib43-20231106","first-page":"Doc01","article-title":"Recurrent urinary tract infections and complications after symptomatic versus antibiotic treatment: follow-up of a randomised controlled trial","volume":"14","year":"2016","journal-title":"Ger Med Sci"},{"issue":"3","key":"bib44-20231106","first-page":"CD001209","article-title":"Antibiotics for preventing recurrent urinary tract infection in non-pregnant women","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"bib45-20231106","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/00365540410019642","article-title":"The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study","volume":"36","year":"2004","journal-title":"Scand J Infect Dis"},{"issue":"7143","key":"bib46-20231106","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/bmj.316.7143.1511","article-title":"Adverse reactions to drugs","volume":"316","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"bib47-20231106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/2231-4040.70513","article-title":"The facts about penicillin allergy: a review","volume":"1","year":"2010","journal-title":"J Adv Pharm Technol Res"},{"issue":"3","key":"bib48-20231106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2500\/108854188779023432","article-title":"The management of patients with sulfonamide allergy","volume":"9","year":"1988","journal-title":"N Engl Reg Allergy Proc"},{"issue":"9","key":"bib49-20231106","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1503\/cmaj.150067","article-title":"Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women","volume":"187","year":"2015","journal-title":"CMAJ"},{"issue":"3","key":"bib50-20231106","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cger.2016.03.002","article-title":"Urinary tract infections in the older adult","volume":"32","year":"2016","journal-title":"Clin Geriatr Med"},{"issue":"7","key":"bib51-20231106","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4140\/TCP.n.2016.381","article-title":"Updated nitrofurantoin recommendations in the elderly: a closer look at the evidence","volume":"31","year":"2016","journal-title":"Consult Pharm"},{"issue":"3","key":"bib52-20231106","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/AAC.47.3.897-900.2003","article-title":"Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women","volume":"47","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"bib53-20231106","first-page":"67","article-title":"A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection","volume":"43","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"bib54-20231106","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/jac\/dkh414","article-title":"Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim\/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study","volume":"54","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"bib55-20231106","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00365540110080728","article-title":"Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women","volume":"34","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"bib56-20231106","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1128\/AAC.42.9.2262","article-title":"Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group","volume":"42","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"bib57-20231106","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0090-4295(01)01562-X","article-title":"Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens","volume":"59","year":"2002","journal-title":"Urology"},{"issue":"11","key":"bib58-20231106","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0149-2918(00)86734-X","article-title":"Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection","volume":"21","year":"1999","journal-title":"Clin Ther"},{"issue":"1","key":"bib59-20231106","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(98)00021-1","article-title":"A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women","volume":"10","year":"1998","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"bib60-20231106","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijantimicag.2003.12.017","article-title":"Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections","volume":"23","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"bib61-20231106","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1128\/AAC.49.10.4137-4143.2005","article-title":"Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"bib62-20231106","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0149-2918(02)80099-6","article-title":"Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women","volume":"24","year":"2002","journal-title":"Clin Ther"},{"issue":"4","key":"bib63-20231106","first-page":"469","article-title":"Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial","volume":"170","year":"2004","journal-title":"CMAJ"},{"issue":"1","key":"bib64-20231106","first-page":"50","article-title":"Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women","volume":"8","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"bib65-20231106","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.293.8.949","article-title":"Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial","volume":"293","year":"2005","journal-title":"JAMA"},{"issue":"7","key":"bib66-20231106","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0149-2918(00)80054-5","article-title":"Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection","volume":"22","year":"2000","journal-title":"Clin Ther"},{"issue":"9","key":"bib67-20231106","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/jac\/dkv147","article-title":"Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"bib68-20231106","first-page":"198","article-title":"Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline","volume":"14","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"bib69-20231106","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/jac\/dkw178","article-title":"Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"bib70-20231106","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin","volume":"15","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"Suppl 2","key":"bib71-20231106","first-page":"79","article-title":"Why fosfomycin trometamol as first line therapy for uncomplicated UTI?","volume":"22","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"bib72-20231106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijantimicag.2006.08.039","article-title":"Fosfomycin in the treatment of extended spectrum beta-lactamase\u2013producing Escherichia coli\u2013related lower urinary tract infections","volume":"29","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"bib73-20231106","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jac\/dkq237","article-title":"Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials","volume":"65","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"bib75-20231106","first-page":"CD001535","article-title":"Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"bib76-20231106","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1086\/426821","article-title":"Is acute uncomplicated urinary tract infection a foodborne illness, and are animals the source?","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"bib77-20231106","first-page":"CD007182","article-title":"Antimicrobial agents for treating uncomplicated urinary tract infection in women","volume":"6","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"bib78-20231106","first-page":"CD004682","article-title":"Duration of antibacterial treatment for uncomplicated urinary tract infection in women","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"bib79-20231106","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/archinte.167.20.2207","article-title":"Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women","volume":"167","year":"2007","journal-title":"Arch Intern Med"},{"issue":"6","key":"bib80-20231106","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s003450050168","article-title":"Pathogenesis and management of recurrent urinary tract infections in women","volume":"17","year":"1999","journal-title":"World J Urol"},{"issue":"2","key":"bib81-20231106","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/21548331.1995.11443143","article-title":"A simplified approach to urinary tract infection","volume":"30","year":"1995","journal-title":"Hosp Pract (Off Ed)"},{"issue":"5","key":"bib82-20231106","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/ki.1996.193","article-title":"Studies on the mechanism of trimethoprim-induced hyperkalemia","volume":"49","year":"1996","journal-title":"Kidney Int"},{"issue":"12","key":"bib83-20231106","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1177\/1060028013509973","article-title":"An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications","volume":"47","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"4","key":"bib84-20231106","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40121-015-0092-8","article-title":"Adverse events associated with fosfomycin use: review of the literature and analyses of the FDA adverse event reporting system database","volume":"4","year":"2015","journal-title":"Infect Dis Ther"},{"issue":"2","key":"bib85-20231106","first-page":"95","article-title":"Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin","volume":"13","year":"1987","journal-title":"Drugs Exp Clin Res"},{"issue":"6","key":"bib86-20231106","first-page":"583","article-title":"Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial","volume":"307","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"bib87-20231106","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7326\/0003-4819-102-3-302","article-title":"Management of recurrent urinary tract infections with patient-administered single-dose therapy","volume":"102","year":"1985","journal-title":"Ann Intern Med"},{"issue":"2","key":"bib88-20231106","first-page":"CD005131","article-title":"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"bib89-20231106","first-page":"2","article-title":"Urinary tract infections in the elderly","volume":"19","year":"1991","journal-title":"Eur Urol"},{"issue":"1","key":"bib90-20231106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-135-1-200107030-00004","article-title":"Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women","volume":"135","year":"2001","journal-title":"Ann Intern Med"},{"issue":"4","key":"bib91-20231106","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0094-0143(05)70057-4","article-title":"Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women","volume":"25","year":"1998","journal-title":"Urol Clin North Am"},{"issue":"6","key":"bib92-20231106","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s11908-011-0212-x","article-title":"Update in adult urinary tract infection","volume":"13","year":"2011","journal-title":"Curr Infect Dis Rep"},{"issue":"2","key":"bib93-20231106","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/514544","article-title":"Antibiotic armageddon","volume":"25","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"bib94-20231106","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1086\/501886","article-title":"Urinary tract infections in long-term-care facilities","volume":"22","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"bib95-20231106","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","article-title":"Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"bib96-20231106","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0891-5520(20)30150-1","article-title":"Recurrent urinary tract infection in adult women: diagnosis and treatment","volume":"1","year":"1987","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"bib97-20231106","doi-asserted-by":"crossref","first-page":"827","DOI":"10.7326\/0003-4819-120-10-199405150-00003","article-title":"Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women?","volume":"120","year":"1994","journal-title":"Ann Intern Med"},{"issue":"2","key":"bib98-20231106","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0022-5347(17)43138-7","article-title":"Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder","volume":"138","year":"1987","journal-title":"J Urol"},{"issue":"9","key":"bib99-20231106","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-114-9-713","article-title":"How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study","volume":"114","year":"1991","journal-title":"Ann Intern Med"},{"issue":"10","key":"bib100-20231106","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/0003-4819-122-10-199505150-00003","article-title":"Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents?","volume":"122","year":"1995","journal-title":"Ann Intern Med"},{"issue":"8","key":"bib101-20231106","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jama.1987.03390080057030","article-title":"Therapy vs no therapy for bacteriuria in elderly ambulatory nonhospitalized women","volume":"257","year":"1987","journal-title":"JAMA"},{"issue":"2","key":"bib102-20231106","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/clinids\/4.2.438","article-title":"Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women","volume":"4","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"Suppl 3","key":"bib103-20231106","first-page":"iii25","article-title":"Complicated urinary tract infections: practical solutions for the treatment of multiresistant gram-negative bacteria","volume":"65","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"bib104-20231106","first-page":"42","article-title":"Diagnosis and management of simple and complicated urinary tract infections (UTIs)","volume":"19","year":"2012","journal-title":"Can J Urol"},{"issue":"5","key":"bib106-20231106","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/003655401750173922","article-title":"Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime","volume":"33","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"Suppl 2","key":"bib107-20231106","first-page":"ii67","article-title":"Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy","volume":"53","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl A","key":"bib108-20231106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/36.suppl_A.145","article-title":"Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group","volume":"36","year":"1995","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"bib109-20231106","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1128\/AAC.00837-08","article-title":"Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl B","key":"bib110-20231106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/32.suppl_B.123","article-title":"Low-dosage cefepime as treatment for serious bacterial infections","volume":"32","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"bib111-20231106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0924-8579(01)00481-2","article-title":"Piperacillin 2 g\/tazobactam 0.5 g is as effective as imipenem 0.5 g\/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections","volume":"19","year":"2002","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"bib112-20231106","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial","volume":"283","year":"2000","journal-title":"JAMA"},{"issue":"6","key":"bib113-20231106","first-page":"CD010446","article-title":"Chinese herbal medicine for treating recurrent urinary tract infections in women","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"bib114-20231106","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijantimicag.2010.05.005","article-title":"Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation","volume":"36","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"bib115-20231106","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/nau.23250","article-title":"The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction","volume":"36","year":"2017","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"bib116-20231106","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0090-4295(94)90249-6","article-title":"Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies","volume":"43","year":"1994","journal-title":"Urology"},{"issue":"1","key":"bib117-20231106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/br.20.1.14-27.1956","article-title":"The properties and mode of action of the polymyxins","volume":"20","year":"1956","journal-title":"Bacteriol Rev"},{"issue":"1","key":"bib118-20231106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s15010-013-0507-y","article-title":"Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature","volume":"42","year":"2014","journal-title":"Infection"},{"issue":"6","key":"bib119-20231106","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.1990.03450060049027","article-title":"Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial","volume":"264","year":"1990","journal-title":"JAMA"},{"issue":"7","key":"bib120-20231106","first-page":"420","article-title":"Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study","volume":"55","year":"2005","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"bib121-20231106","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-92-6-770","article-title":"Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial","volume":"92","year":"1980","journal-title":"Ann Intern Med"},{"issue":"2","key":"bib122-20231106","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF01833874","article-title":"A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection","volume":"23","year":"1995","journal-title":"Infection"},{"issue":"1","key":"bib123-20231106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jac\/16.1.111","article-title":"A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections","volume":"16","year":"1985","journal-title":"J Antimicrob Chemother"},{"issue":"294","key":"bib124-20231106","first-page":"811","article-title":"Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women","volume":"81","year":"1991","journal-title":"Q J Med"},{"issue":"1","key":"bib125-20231106","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/00365548509070428","article-title":"Trimethoprim alone compared to co-trimoxazole in lower respiratory infections: pharmacokinetics and clinical effectiveness","volume":"17","year":"1985","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"bib126-20231106","first-page":"669","article-title":"Cinoxacin vs trimethoprim\u2014safety and efficacy in the prophylaxis of uncomplicated urinary tract infections","volume":"14","year":"1988","journal-title":"Drugs Exp Clin Res"},{"issue":"5","key":"bib127-20231106","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0022-5347(17)39055-9","article-title":"Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin","volume":"142","year":"1989","journal-title":"J Urol"},{"issue":"5","key":"bib128-20231106","first-page":"274","article-title":"Recurrent cystitis in nonpregnant women","volume":"170","year":"1999","journal-title":"West J Med"},{"issue":"6","key":"bib129-20231106","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0022-5347(17)49347-5","article-title":"Effect of prophylactic, low dose cephalexin on fecal and vaginal bacteria","volume":"133","year":"1985","journal-title":"J Urol"},{"issue":"Suppl 38","key":"bib130-20231106","first-page":"36","article-title":"Antimicrobial prophylaxis in women with recurrent urinary tract infections","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"bib131-20231106","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bpobgyn.2005.08.003","article-title":"Recurrent urinary tract infections","volume":"19","year":"2005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"14","key":"bib132-20231106","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archinternmed.2011.306","article-title":"Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women","volume":"171","year":"2011","journal-title":"Arch Intern Med"},{"issue":"7425","key":"bib133-20231106","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bmj.327.7425.1204","article-title":"Recurrent urinary tract infection in women","volume":"327","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"bib134-20231106","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1074\/jbc.M110560200","article-title":"Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli","volume":"277","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"bib135-20231106","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.0308125100","article-title":"Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis","volume":"101","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"bib136-20231106","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1128\/IAI.69.7.4572-4579.2001","article-title":"Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection","volume":"69","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"bib137-20231106","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"5","key":"bib138-20231106","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","article-title":"A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women","volume":"180","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"bib139-20231106","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","article-title":"Vaginal estrogen for genitourinary syndrome of menopause: a systematic review","volume":"124","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"6","key":"bib140-20231106","first-page":"1045","article-title":"Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors","volume":"98","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"4","key":"bib141-20231106","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1471-0528.1998.tb10124.x","article-title":"Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women","volume":"105","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"bib142-20231106","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/374341","article-title":"Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women","volume":"36","year":"2003","journal-title":"Clin Infect Dis"},{"key":"bib143-20231106","first-page":"CD003265","article-title":"Methenamine hippurate for preventing urinary tract infections","volume":"10","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"bib144-20231106","first-page":"41","article-title":"Management of recurrent urinary tract infections in healthy adult women","volume":"15","year":"2013","journal-title":"Rev Urol"},{"issue":"3","key":"bib145-20231106","first-page":"229","article-title":"Bacterial vaginosis: a review on clinical trials with probiotics","volume":"36","year":"2013","journal-title":"New Microbiol"},{"issue":"1","key":"bib146-20231106","first-page":"6607","article-title":"Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis","volume":"20","year":"2013","journal-title":"Can J Urol"},{"issue":"12","key":"bib147-20231106","first-page":"CD008772","article-title":"Probiotics for preventing urinary tract infections in adults and children","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"bib148-20231106","first-page":"988","article-title":"Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials","volume":"172","year":"2012","journal-title":"Arch Intern Med"},{"key":"bib149-20231106","first-page":"CD001321","article-title":"Cranberries for preventing urinary tract infections","volume":"10","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"bib150-20231106","first-page":"97","article-title":"Effect of d-mannose and d-glucose on Escherichia coli bacteriuria in rats","volume":"11","year":"1983","journal-title":"Urol Res"},{"issue":"1","key":"bib151-20231106","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00345-013-1091-6","article-title":"D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial","volume":"32","year":"2014","journal-title":"World J Urol"},{"issue":"10","key":"bib152-20231106","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sc.1996.105","article-title":"The possible value of ascorbic acid as a prophylactic agent for urinary tract infection","volume":"34","year":"1996","journal-title":"Spinal Cord"},{"issue":"7","key":"bib153-20231106","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/00016340701273189","article-title":"Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy","volume":"86","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"bib154-20231106","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.eururo.2010.12.039","article-title":"Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial","volume":"59","year":"2011","journal-title":"Eur Urol"},{"issue":"9","key":"bib155-20231106","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1464-410X.2004.04850.x","article-title":"Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study","volume":"93","year":"2004","journal-title":"BJU Int"},{"issue":"12","key":"bib156-20231106","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00192-012-1794-z","article-title":"Effectiveness of intravesical hyaluronic acid\/chondroitin sulfate in recurrent bacterial cystitis: a randomized study","volume":"23","year":"2012","journal-title":"Int Urogynecol J"},{"issue":"3","key":"bib157-20231106","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijgo.2006.11.025","article-title":"Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid","volume":"96","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"bib158-20231106","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0094-0143(21)00262-7","article-title":"Pathogenesis of urinary tract infections. Bacterial adherence, bladder defense mechanisms","volume":"13","year":"1986","journal-title":"Urol Clin North Am"},{"issue":"6","key":"bib159-20231106","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.juro.2013.04.142","article-title":"Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials","volume":"190","year":"2013","journal-title":"J Urol"}],"container-title":["Female Pelvic Medicine &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01436319-201809000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:00:09Z","timestamp":1765609209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01436319-201809000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":155,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/spv.0000000000000550","relation":{},"ISSN":["2151-8378"],"issn-type":[{"value":"2151-8378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}